Connexin Distribution in Physiological Versus Pathological Cardiac Hypertrophy

生理性与病理性心脏肥大中的连接蛋白分布

基本信息

  • 批准号:
    8391535
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-10-01 至 2013-09-30
  • 项目状态:
    已结题

项目摘要

Research supported by this grant during the previous twenty-four years has been built around extensive data showing that cardiac structure, composition, and function each respond rapidly and reversibly to changes in hemodynamic load. The first set of studies supported by this grant used isolated cells, or cardiocytes, and intact animals to demonstrate the role of load as a central regulator of cardiocyte growth. The second set of studies supported by this grant, which also used load change as the primary experimental variable, led to our discovery of a dense cardiocyte microtubule network during severe pressure-overload cardiac hypertrophy that contrib- utes to the contractile dysfunction which occurs in this setting. The initial goals for the subsequent studies of this abnormal microtubule network were to determine how it contributes to the contractile dysfunction of hypertrophied myocardium. Major findings have been that 1) it is based both on increased tubulin, and thus microtubules, and on greater microtubule stability, 2) the major car- diac microtubule-stabilizing microtubule-associated protein, MAP4, is greatly upregulated in pressure overload hypertrophy and binds extensively to microtubules, and 3) contractile dysfunction is caused by viscous loading imposed on shortening myofilaments by the dense microtubule network. However, the most important normal role of the microtubules in an interphase cell such as the cardiocyte is not to determine cellular rheological properties but rather to subserve intracellular transport of macromolecules and vesicles via the microtubule-associated kinesin and dynein families of motor proteins. Indeed, this is an absolutely essential role in the extremely diffusion-restricted cytoplasm of the adult cardiocyte. For this reason, and because of the known inhibition of microtubule-dependent intracellular transport by excessive decoration of microtubules with MAPs, we next asked if microtubule-based transport of the activated ¿-adrenergic receptor and/or mRNA - ribonucleoprotein complexes was inhibited by MAP4 binding to microtubules in pressure- overload hypertrophy. Such, in fact. was the case. Building on this most recent work, we propose to examine here the potential role of alterations in microtubule network organization and MAP4 binding in causing abnormal transport and localization of connexin43 [Cx43], a gap junction protein known to undergo functionally important alterations in quantity and localization during pathological cardiac hypertrophy. The basic research in the first objective will use isolated cells as well as oper- ated and transgenic mice to determine whether MAP4 decoration of microtubules, and the attendant densifica- tion of the microtubule network, inhibit the normal transport of Cx43 to gap junctions as well as Cx43-depen- dent electrophysiological function. The translational research in the second and third objectives will compare an equal degree & duration of pathological pressure vs. physiological volume overload hypertrophy. We will first extend the findings of the first objective to ask if MAP4 decoration of the dense microtubule network in pathological hypertrophy has a role in the altered Cx43 transport and localization that are important clinically in forming an arrhythmogenic substrate. We will then ask if ¿-receptor blockade in pathological hypertrophy, which early data indicates will prevent the abnormal microtubule phenotype, will also prevent the abnormal Cx43 phenotype in this setting. In the first objective we will use murine models, and in the second and third objectives we will use our long- standing feline models of physiological versus pathological hypertrophy. While we recognize that it is prefer- able to use a single species, in this research the initial mechanistic portion can only be done in the mouse, but the later quantitative translational portions require very reproducible animal models that can be reliably and verifiably ¿-blocked and have an equivalent degree and duration of physiological vs. pathological hypertrophy, with ex- tensively characterized cytoskeletal properties in each setting.
过去 24 年中这项拨款支持的研究是围绕大量数据建立的 表明心脏的结构、组成和功能都对心脏的变化做出快速且可逆的反应 血流动力学负荷。此项资助支持的第一组研究使用了分离的细胞或心肌细胞,以及完整的细胞。 动物证明负荷作为心肌细胞生长的中央调节器的作用。第二组研究 在这项资助的支持下,该资助也使用负荷变化作为主要实验变量,导致我们发现 严重压力超负荷心脏肥大期间致密心肌细胞微管网络的形成 导致在这种情况下发生的收缩功能障碍。 随后对这种异常微管网络进行研究的最初目标是确定它是如何形成的。 导致肥厚心肌的收缩功能障碍。主要发现是 1) 基于增加的微管蛋白和微管,以及更大的微管稳定性,2)主要的汽车 diac 微管稳定微管相关蛋白 MAP4 在压力超负荷时大幅上调 肥大并与微管广泛结合,3) 收缩功能障碍是由粘性负荷引起的 通过致密的微管网络来缩短肌丝。 然而,微管在间期细胞(如心肌细胞)中最重要的正常作用是 不是为了确定细胞流变特性,而是为了促进大分子的细胞内运输 和囊泡通过运动蛋白的微管相关驱动蛋白和动力蛋白家族。确实,这是一个 在成年心肌细胞的极度扩散限制的细胞质中起着绝对重要的作用。为此原因, 并且由于已知过度装饰会抑制微管依赖性细胞内运输 具有 MAP 的微管,我们接下来询问激活的 ¿-肾上腺素受体是否基于微管进行运输 和/或 mRNA - 核糖核蛋白复合物在压力下被 MAP4 与微管的结合所抑制 超负荷肥大。事实上,就是这样。情况就是如此。 基于这项最新工作,我们建议在此研究微管改变的潜在作用 网络组织和 MAP4 结合导致 connexin43 [Cx43] 的异常运输和定位, 一种间隙连接蛋白,已知在数量和定位过程中会发生功能上重要的改变 病理性心肌肥厚。第一个目标的基础研究将使用分离的细胞以及操作 小鼠和转基因小鼠以确定 MAP4 是否修饰微管以及随之而来的致密化 微管网络的重合,抑制 Cx43 到间隙连接的正常转运以及 Cx43 依赖性 削弱电生理功能。第二个和第三个目标的转化研究将进行比较 病理性压力与生理性容量超负荷肥大的程度和持续时间相同。我们将 首先扩展第一个目标的发现,询问密集微管网络的 MAP4 修饰是否存在于 病理性肥大在 Cx43 运输和定位改变中发挥作用,这在临床上很重要 形成致心律失常基质。然后我们会问病理性肥大中是否存在 ¿-受体阻断,这 早期数据表明会预防微管表型异常,也会预防Cx43异常 在此设置中的表型。 在第一个目标中,我们将使用小鼠模型,在第二个和第三个目标中,我们将使用我们的长期研究 生理性与病理性肥大的站立猫模型。虽然我们认识到这是更可取的 由于能够使用单一物种,在这项研究中,最初的机械部分只能在小鼠中完成,但是 后期的定量转化部分需要非常可重复的动物模型,可以可靠且可验证 ¿-阻断并具有同等程度和持续时间的生理性与病理性肥大,前- 在每种情况下都集中表征了细胞骨架特性。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Prediction of All-Cause Mortality Based on the Direct Measurement of Intrathoracic Impedance.
  • DOI:
    10.1161/circheartfailure.115.002543
  • 发表时间:
    2016-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Zile MR;Sharma V;Johnson JW;Warman EN;Baicu CF;Bennett TD
  • 通讯作者:
    Bennett TD
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael R Zile其他文献

1058-69 Modeling and prediction of acute hemodynamic effects of an arterial assist device
  • DOI:
    10.1016/s0735-1097(04)91705-6
  • 发表时间:
    2004-03-03
  • 期刊:
  • 影响因子:
  • 作者:
    Salvatore A Chiaramida;Naveen L Pereira;Michael R Zile;Christopher D Nielsen;Adrian B VanBakel;Donna M Meyer;Ying Sun
  • 通讯作者:
    Ying Sun

Michael R Zile的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael R Zile', 18)}}的其他基金

Extracellular Matrix in Hypertensive Heart Disease & Transition to Heart Failure
高血压心脏病中的细胞外基质
  • 批准号:
    9477758
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Extracellular Matrix in Hypertensive Heart Disease & Transition to Heart Failure
高血压心脏病中的细胞外基质
  • 批准号:
    9100853
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Extracellular Matrix in Hypertensive Heart Disease & Transition to Heart Failure
高血压心脏病中的细胞外基质
  • 批准号:
    9273602
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Extracellular Matrix in Hypertensive Heart Disease & Transition to Heart Failure
高血压心脏病中的细胞外基质
  • 批准号:
    8903566
  • 财政年份:
    2014
  • 资助金额:
    --
  • 项目类别:
AGE/RAGE Interaction in Patients with Pressure Overload-Induced Heart Failure
压力过载诱发心力衰竭患者中 AGE/RAGE 的相互作用
  • 批准号:
    8257862
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
AGE/RAGE Interaction in Patients with Pressure Overload-Induced Heart Failure
压力过载诱发心力衰竭患者中 AGE/RAGE 的相互作用
  • 批准号:
    8698368
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
AGE/RAGE Interaction in Patients with Pressure Overload-Induced Heart Failure
压力过载诱发心力衰竭患者中 AGE/RAGE 的相互作用
  • 批准号:
    8140701
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
AGE/RAGE Interaction in Patients with Pressure Overload-Induced Heart Failure
压力过载诱发心力衰竭患者中 AGE/RAGE 的相互作用
  • 批准号:
    8392975
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
DIASTOLIC HEART FAILURE: DEFINING CARDIOCYTE MECHANISMS
舒张性心力衰竭:定义心肌细胞机制
  • 批准号:
    6808271
  • 财政年份:
    2003
  • 资助金额:
    --
  • 项目类别:
CORE-- MODEL
核心——模型
  • 批准号:
    6808276
  • 财政年份:
    2003
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了